Posted: September 21, 2018 | News, Press

Amsino Medical Group to Acquire Smiths Medical’s Vernon Hills’s Manufacturing Plant

Pomona, Ca — Amsino Healthcare (USA), Inc., a fully owned subsidiary of Amsino Medical Group (“Amsino”) has signed a definitive agreement with Smiths Medical ASD, Inc. (Smiths) to acquire the assets of Smiths’ manufacturing plant located in Vernon Hills, IL (VH).  The transaction includes all assets and infrastructure that currently exist in the facility. The plant has been a long-time FDA registered pharmaceutical manufacturer of essential inhalation therapy, wound care and other USP grade saline/water based products for the medical device and pharmaceutical industries.  The acquisition is in alignment with Amsino’s strategic global expansion goals and its mission to improve the safety and effectiveness of patient care worldwide.  The transaction is expected to close in the second half of 2018.

“We look forward to expanding the current business and becoming the ‘go-to’ company for USP grade water and saline based products for the global medical device and pharmaceutical industry” said Dr. Richard Lee, Chairman and CEO of Amsino. 

“We see great synergy between this product line and Amsino’s strategic goals” said Mark McDonald, Senior Vice President of Global Operations for Smiths Medical, and he added “Over the coming months we look forward to working closely with Amsino to ensure a smooth integration and transition process.” 

Amsino plans to retain all current employees of the plant with plans for continual operational expansion and investment. Amsino believes that this strategic acquisition will position Amsino for significant growth as it enters new markets with expanded product offerings and grows existing market share with the production of ancillary products to its existing lines.


About Amsino Medical Group

Established in the U.S. in 1993, Amsino develops, manufactures and markets medical products that help improve the safety and effectiveness of patient care under a portfolio of globally recognized Amsino brands. The company operates several U.S. FDA qualified manufacturing and R&D facilities globally under ISO13485 quality management system. Visit for more information.